Chemed Corp. Q2 Earnings Call: Assessing the Outlook and Market Sentiment

August 11, 2023


The highly-anticipated Q2 earnings call for Chemed Corp. is just around the corner, scheduled for July 27th, 2023 at 10:00 AM EST. As equity analysts, we have combed through the available data to provide you with a comprehensive assessment of the upcoming earnings call. In this article, we will delve into fundamental and technical analysis, historical guidance, and analysts’ estimates, in order to provide a holistic view of Chemed Corp.‘s financial performance. Join us as we unveil the details and shed light on the market sentiment surrounding this earnings call.

Fundamental Analysis:

ReportDate NetIncome TotalRevenue DilutedEPS unit
Q2 2023-06-30 53.4 553.8 3.51 million USD
Q1 2023-03-31 54.1 560.2 3.58 million USD
Q4 2022-12-31 62.1 546.7 4.13 million USD
Q3 2022-09-30 56.9 526.5 3.78 million USD
Q2 2022-06-30 66.5 531.3 4.40 million USD

Chemed Corp., a leading provider of healthcare and maintenance services, has consistently displayed strong fundamentals. Looking at the past year’s financials, we observe steady revenue growth. In Q2 2023, the company reported a net income of $53.4 million on a total revenue of $553.8 million. This reflects resilience in the face of challenging market conditions. Moreover, Chemed Corp.‘s diluted EPS stood at $3.51 million USD, showcasing their ability to manage costs effectively.

Technical Analysis:

since low high change change%
1D 2023-08-09 509.9 513.5 -2.6 -0.5
5D 2023-08-03 509.9 522.7 -4.3 -0.8
1M 2023-07-11 507.3 574.7 -19.5 -3.7
3M 2023-05-08 507.3 574.7 -40.8 -7.4

Taking a closer look at Chemed Corp.‘s price performance over the past three months, we witness fluctuations within a certain range. While the stock experienced a downward trend in recent days, it is important to note that the stock had shown considerable gains in previous periods. It is crucial to approach technical analysis with caution, considering various factors such as market sentiment and institutional holdings.

Historical Guidance:

The consistency in MorningStar’s consensus estimates for Chemed Corp.‘s adjusted EPS for this quarter is noteworthy. Over the past 90 days, the estimate has remained unchanged at $5.03. This uniformity suggests that analysts have confidence in the company’s ability to meet or exceed expectations. Chemed Corp.‘s historical guidance also supports this optimism, as the past year has demonstrated solid financial performance.

Analysts’ Estimates:

Given the stability in historical guidance, analysts’ estimates for Chemed Corp.‘s Q2 earnings call are likely to be aligned with the consensus estimate of $5.03 for adjusted EPS. However, it is essential to consider that market dynamics and unforeseen events can impact actual results. Analysts attending the earnings call will seek clarification on key areas, such as revenue growth, margin expansion, and operational efficiencies. The management’s guidance for future quarters will also play a crucial role in shaping market sentiment and investor perception.

Market Sentiment:

Market sentiment surrounding Chemed Corp.‘s upcoming earnings call is mostly positive, as indicated by recent news sentiment. This optimism can be attributed to the company’s consistent performance in recent quarters and the positive market reception to its products and services. Chemed Corp.‘s commitment to innovation and its ability to adapt to changing market dynamics have garnered investor confidence. As investors tune in to the earnings call, they will be eager to hear about the company’s strategies for sustaining its growth trajectory and capitalizing on emerging opportunities.


Anticipation is building as Chemed Corp. prepares to report its Q2 earnings results. The fundamental and technical analysis, historical guidance, and analysts’ estimates all point towards a positive outlook for the company. Despite recent fluctuations in the stock price, Chemed Corp.‘s strong financial performance and market sentiment indicate that investors should remain optimistic.

Tune in to Chemed Corp.‘s Q2 earnings call on July 27th, 2023, at 10:00 AM EST, as the management unveils their financial performance, discusses strategic initiatives, and provides insights into future prospects. By participating in this call, investors will gain valuable information and further understand the factors that drive Chemed Corp.‘s success.

Disclaimer: The above analysis is based on the available data as of the time of writing and does not constitute financial advice. Investors are encouraged to conduct their own research and consult with a financial advisor before making any investment decisions.

Recent Posts

Leave a Comment